Page results
-
UCLH is to trial a COVID-19 vaccine developed by Imperial College London.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
Today is the 72 anniversary of the NHS – and it is dedicated to our amazing staff.
-
Tens of thousands of people in England who have hepatitis C could now get tested and treated thanks to a new mobile health unit arriving to coincide with World Hepatitis Day on 28 July.
-
An evaluation of temporary changes to children and young people’s services in North Central London (NCL) in the autumn and winter of 2020/21 has been published.
-
A major new consortium led by UCLH and UCL has been awarded £6.8 million by the National Institute of Health Research to conduct the largest clinical study of long COVID over the next two years.
-
In May 2020, UCLH invited acclaimed photographer Tom Pilston to take portraits of staff at the height of the Covid-19 pandemic.
-
UCLH will be part of a first-of-its kind clinical trial, led by scientists at UCL, that will evaluate the use of ‘real time’ viral genomic data to reduce the spread of COVID-19 within hospitals.
-
UCLH chair Baroness Julia Neuberger has today announced that Professor Marcel Levi will be stepping down from his role as UCLH chief executive on 31 March 2021.
-
Two doses of the Oxford-AstraZeneca COVID-19 vaccine induce lower levels of antibodies that are able to recognise and fight the SARS-CoV-2 Delta variant (B.1.617.2) than against other strains, according to laboratory findings from UCLH and the Francis Crick Institute.
File results
-
FOI/2021/0601 - Treatment Guidelines with Systemic lupus erythematosus (SLE) / Lupus nephritis (LN)
-
FOI/2021/0616 - Overseas visitors and migrants
-
FOI/2021/0618 - Number of patient admissions to A&E
-
FOI/2021/0626 - Cardiac output monitors and manufacturer associated disposable products
-
FOI/2021/0100 - DNACPR orders issued - March 2019 to January 2021
-
FOI/2021/0091 - Patients admitted with respiratory conditions - SARS-COV-2
-
FOI/2021/0421 - Academic doctors working in Trauma and Orthopaedics
-
FOI/2021/0038 - Agency nurses - October 2020 – January 2021
-
FOI/2021/0648 - Top five ON framework 3rd Party providers for nursing staff
-
FOI/2021/0379 - Physical assaults/ physical injuries to staff